Argentines living with HIV/AIDS and medics say spending cuts under libertarian President Javier Milei are hurting treatment ...
Interesting Engineering on MSN2m
From chronic to curable: Twice-yearly shot shows near-total HIV eradicationScientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.
Argentina's HIV/AIDS treatment programs are facing cuts under President Milei's austerity measures, reducing budgets by 67% ...
Argentinian President Javier Milei has raised concerns for the HIV/AIDS patients and medics with his fiscal deficit ...
Another drugmaker, Viiv Healthcare, also left out most of Latin America when it allowed generics of its HIV prevention shot ...
Argentina's HIV patients and healthcare providers voice concerns over spending cuts by President Javier Milei, fearing ...
Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...
In a report issued to mark World AIDS Day on Sunday, UNAIDS said that the number of AIDS deaths last year—an estimated ...
Discover the groundbreaking results of Lenacapavir, a twice-yearly injection that reduces HIV infection risk offering an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback